Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrum.

Greenawalt, Danielle M; Liang, Winnie S; Saif, Sakina; Johnson, Justin; Todorov, Petar; Dulak, Austin; Enriquez, Daniel; Halperin, Rebecca; Ahmed, Ambar; Saveliev, Vladislav; Carpten, John; Craig, David; Barrett, J Carl; Dougherty, Brian; Zinda, Michael; Fawell, Stephen; Dry, Jonathan R; Byth, Kate

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.

Greenawalt, Danielle M; Liang, Winnie S; Saif, Sakina; Johnson, Justin; Todorov, Petar; Dulak, Austin; Enriquez, Daniel; Halperin, Rebecca; Ahmed, Ambar; Saveliev, Vladislav; Carpten, John; Craig, David; Barrett, J Carl; Dougherty, Brian; Zinda, Michael; Fawell, Stephen; Dry, Jonathan R; Byth, Kate.

Afiliação

Greenawalt DM; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Liang WS; Current address: Translational Bioinformatics, Bristol-Myers Squibb Company, Hopewell, NJ, USA.
Saif S; Translational Genomics Research Institute, Phoenix AZ, USA.
Johnson J; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Todorov P; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Dulak A; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Enriquez D; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Halperin R; Translational Genomics Research Institute, Phoenix AZ, USA.
Ahmed A; Translational Genomics Research Institute, Phoenix AZ, USA.
Saveliev V; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Carpten J; Center for Algorithmic Biotechnology, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
Craig D; Translational Genomics Research Institute, Phoenix AZ, USA.
Barrett JC; Translational Genomics Research Institute, Phoenix AZ, USA.
Dougherty B; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Zinda M; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Fawell S; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Dry JR; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.
Byth K; Oncology Innovative Medicines and Early Development, AstraZeneca R&D Boston, Waltham, MA, USA.